Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Wednesday, February 22, 2012

Johnson & Johnson CEO resigns

LINK HERE: CNN story on sudden resignation of J&J CEO.

Multiple failures of leadership led to catastrophic patient harm and cost taxpayers millions of dollars.  Trust is broken.  The person accountable for these "business decisions" and "missteps" is allowed to resign and retain his fortune.  This is not justice.  This will not deter others from continuing the corruption of our health system.

No comments:

Post a Comment